FIG

Figma, Inc.

$22.71

+5.43% 2026-10-20

Technology

1M 3M 6M 1Y 2Y

FIGSPY

+4.4%

+0.1%

+3.6%

+21.3%

YTD

-39.2%

-59.2%

Live chart

Loading live chart…

What they do

Figma, Inc. develops and sells a collaborative, browser-based platform for designing, prototyping, building digital experiences, and subscriptions for access to its platform. The company offers Figma Design, a collaborative design tool for teams that explore ideas and gather feedback, build realistic prototypes. It also provides Figma Draw to create expressive designs with illustration tools.

Technology · Software - Application

Grades vs sector

Momentum

Not enough data yet

–

Percentile within its GICS sector across the S&P 1500.

Growth

Not enough data yet

–

Percentile within its GICS sector across the S&P 1500.

Value

Not enough data yet

–

Percentile within its GICS sector across the S&P 1500.

Profitability

Not enough data yet

–

Percentile within its GICS sector across the S&P 1500.

Revisions

Not enough data yet

–

30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 5 live models right now.

Quality Growth

not ranked (outside this model's universe or screens)

Momentum Top 15

not ranked (outside this model's universe or screens)

Momentum Blend

not in the current book

New Highs Growth

not ranked (outside this model's universe or screens)

Conviction 20

not in the current book

News

More news

Has Figma (FIG) Fallen Far Enough To Look Reasonable?

Simply Wall St. · Oct 15

Better High-Growth Software Stock for 2026: Figma vs. ServiceNow

Motley Fool · Oct 15

Figma vs. Palantir Technologies: Which Technology Stock Is a Better Buy in 2026?

Motley Fool · Oct 15

Ramp reaches $60B valuation as it pushes deeper into AI

TechCrunch · Oct 15

YouTube Changed Video. Are Audiobooks Its Next Frontier?

The Wall Street Journal · Oct 15

Key stats

Market cap$12.1B

P/E (trailing)–

P/E (forward)65.9

52-week range16.60 – 57.25

Revenue growth (YoY, latest qtr)+48.2%

Dividend yield0.00%

Analyst consensusBuy (10)

Mean price target$30.10 (+33%)

Valuation and fundamentals

Valuation & fundamentals

Bottom line

Looks undervalued

Model read-out from the numbers below, not advice. Score +3 (DCF counts double).

▲DCF (base case)above the price by 42%

•Piotroski F-score4/9

▲Altman Z6.2 (safe)

▲Analyst target+33% (10 analysts)

Discounted cash flow

Bear

$16

-30%

growth 18% · disc. 10.2% · term. 2.0%

Base

$32

+42%

growth 30% · disc. 9.2% · term. 2.5%

Bull

$59

+158%

growth 38% · disc. 8.2% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal

Today's price assumes free cash flow grows about 17% a year for 10 years.

Implied

+17%/yr

FCF, last 3 yrs

n/a

FCF, last 5 yrs

n/a

Revenue, last 3 yrs

n/a

Revenue, last 5 yrs

n/a

Same inputs as the DCF above: trailing free cash flow 0.2B, 9.2% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.00 (n/a) × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs sector

Forward EPS $0.34 vs trailing $-3.23. Forward P/E uses analysts' next-12-month estimate.

Backlog (remaining performance obligations)

RPO

$687.0M

as of 2026-06-30

vs a year ago

+53%

YoY

× TTM revenue

0.54×

coverage

25-06

25-09

25-12

26-03

26-06

Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).

Quality & financial health

Gross margin

79.1%

Operating margin

-123.8%

FCF margin

18.1%

Net margin

-123.1%

Return on equity

-106.8%

Return on invested capital

–

Net debt / EBITDA

–

Current ratio

2.5×

Interest cover

–

Cash conversion (OCF/NI)

–

Piotroski F-score 4/9 · last two fiscal years

✗ Positive net income✓ Positive operating cash flow✗ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✗ No share dilution✗ Gross margin improved✓ Asset turnover improved

Altman Z-score 6.2 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target

$30

+33%

Analysts

Buy

Range

$22–$37

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$1.1B	$-1.3B	$246.2M
2024	$749.0M	$-732.1M	$-63.7M
2023	$504.9M	$737.8M	$1.0B

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR –.

Earnings

Next report: 2026-11-04 · during market · EPS est 0.05

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-08-05	0.05	0.08	+74.8%
2026-05-14	0.06	0.10	+61.0%
2026-02-18	0.06	0.08	+23.7%
2025-11-05	0.05	0.13	+182.3%
2025-09-03	0.08	0.09	+11.0%

Quarterly revenue

Quarter	Revenue	YoY
2026-06-30	$370.1M	+48.2%
2026-03-31	$333.4M	–
2025-12-31	$303.8M	–
2025-09-30	$274.2M	–
2025-06-30	$249.6M	–

Analyst actions

Stifel

2026-10-14 · main

Hold → Hold
PT $22

Wells Fargo

2026-10-13 · main

Overweight → Overweight
PT $30

Keybanc

2026-09-14 · init

→ Sector Weight

B of A Securities

2026-08-19 · main

Buy → Buy
PT $33

Citigroup

2026-08-07 · main

Buy → Buy
PT $37

Citigroup

2026-07-24 · main

Buy → Buy
PT $35

Insider trades

Radakovich Lynn Vojvodich

Director · 2026-10-15

SELL
$77.1K

Radakovich Lynn Vojvodich

Director · 2026-10-15

SELL
$381.4K

Herb Tyler

Chief Accounting Officer · 2026-10-05

SELL
$30.7K

Mulligan Brendan

General Counsel and Secretary · 2026-10-05

SELL
$450.0K

Mulligan Brendan

General Counsel and Secretary · 2026-09-03

SELL
$1.7M

Mulligan Brendan

General Counsel and Secretary · 2026-09-03

SELL
$1.2M

Herb Tyler

Chief Accounting Officer · 2026-09-03

SELL
$37.2K

Mulligan Brendan

General Counsel and Secretary · 2026-08-28

SELL
$2.4M

Mulligan Brendan

General Counsel and Secretary · 2026-08-28

SELL
$3.9M

Mulligan Brendan

General Counsel and Secretary · 2026-08-28

SELL
$3.1K

Herb Tyler

Chief Accounting Officer · 2026-08-27

SELL
$60.0K

Herb Tyler

Chief Accounting Officer · 2026-08-21

SELL
$49.9K

Stats refreshed 2026-10-20 18:13:39 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

COTEAU

Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.

How it works Disclaimer Terms Privacy Data status